Amidst the global race for vaccines, Africa is gearing up for a groundbreaking milestone that doesn’t involve sending anything into space but promises to uplift millions on the ground – eight home-grown vaccines in the pipeline set to launch within four years. The continent may witness the dawn of its first wave of fully “Made-in-Africa
” vaccines as early as 2029, revealed Dr. Jean Kaseya, Director-General of Africa Centres for Disease Control and Prevention (Africa CDC).
In a recent press briefing, Dr. Kaseya shared exciting news about the progress being made in developing these indigenous vaccines tailored specifically for African populations. He expressed optimism by stating, “
We will celebrate eight vaccines, made by Africans, for Africans.
” While keeping specifics under wraps, he mentioned that these vaccines are targeting crucial diseases and are progressing through an African manufacturing chain. Moreover, they will benefit from a continent-wide pooled-procurement platform aimed at ensuring competitive pricing upon their launch.
The strategic move towards self-reliance in vaccine production is not just about innovation but also about reshaping Africa’s healthcare landscape from reactive emergency responses to proactive preventive measures deeply rooted in primary health care systems. As part of this transformation, Africa CDC has appointed its first Director for Primary Health Care and is actively training community health workers to proactively identify and contain outbreaks before they escalate.
Dr. Kaseya emphasized the importance of prevention over cure by stating emphatically, “
Prevention isn’t a slogan — it’s cheaper, faster and worth every cent when outbreaks strike.” This shift signifies a departure from depending heavily on external funding for vaccination campaigns towards fostering self-sufficiency and sustainability within the region.
Addressing concerns about reliance on external aid agencies, Dr. Kaseya issued a strong message urging partners to align with Africa’s agenda rather than dictating terms. He stressed the need for genuine collaboration that respects Africa’s autonomy and vision without veering off course due to external influences.
Drawing inspiration from successful models like the Pan-American Health Organization’s revolving fund, Africa CDC is poised to establish procurement agreements very soon. These agreements are anticipated to solidify partnerships with suppliers essential for advancing the vaccine manufacturing process across various African nations where existing facilities can contribute significantly once clinical trials and regulatory approvals are obtained.
While Dr. Kaseya’s vision may seem ambitious, industry observers point out that several African manufacturers possess the necessary infrastructure capable of producing and packaging vaccines once all regulatory hurdles are cleared—a promising sign towards achieving local vaccine sovereignty.
As Africa embarks on this transformative journey towards self-sufficiency in vaccine production and public health preparedness through innovative solutions like home-grown vaccinations spearheaded by passionate leaders like Dr. Jean Kaseya at the helm of Africa CDC’s initiatives.
Leave feedback about this